Cargando…
Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
Non-valvular atrial fibrillation is becoming more common in Australia and globally The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin Patient preferences are important and shared decision-making supports better adherence to treatment
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
NPS MedicineWise
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075749/ https://www.ncbi.nlm.nih.gov/pubmed/33911332 http://dx.doi.org/10.18773/austprescr.2021.002 |
| _version_ | 1783684580881989632 |
|---|---|
| author | Lindley, Richard I |
| author_facet | Lindley, Richard I |
| author_sort | Lindley, Richard I |
| collection | PubMed |
| description | Non-valvular atrial fibrillation is becoming more common in Australia and globally The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin Patient preferences are important and shared decision-making supports better adherence to treatment |
| format | Online Article Text |
| id | pubmed-8075749 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | NPS MedicineWise |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80757492021-04-27 Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation Lindley, Richard I Aust Prescr Article Non-valvular atrial fibrillation is becoming more common in Australia and globally The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin Patient preferences are important and shared decision-making supports better adherence to treatment NPS MedicineWise 2021-04-01 2021-04 /pmc/articles/PMC8075749/ /pubmed/33911332 http://dx.doi.org/10.18773/austprescr.2021.002 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
| spellingShingle | Article Lindley, Richard I Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title | Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title_full | Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title_fullStr | Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title_full_unstemmed | Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title_short | Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| title_sort | balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075749/ https://www.ncbi.nlm.nih.gov/pubmed/33911332 http://dx.doi.org/10.18773/austprescr.2021.002 |
| work_keys_str_mv | AT lindleyrichardi balancingthebenefitsandharmsoforalanticoagulationinnonvalvularatrialfibrillation |